Prognosis Prediction for Stage II Colorectal Cancer by Fusing CT Radiomics and Deep Learning Features of Primary Lesion and Peripheral Lymph Nodes

Menglei Li,Jing Gong,Yichao Bao,Dan Huang,Junjie Peng,Tong Tong
DOI: https://doi.org/10.2139/ssrn.3736713
2020-01-01
Abstract:Purpose: This study aims to compare the performance of radiomics features and deep learning (DL) features in predicting the prognostic of stage II colorectal cancer (CRC) patients, and fuse these two types of imaging features of primary lesion and peripheral lymph nodes (LNs) to improve the prediction performance. Materials and Methods: We first collected 230 patients (170 in the training set; 60 in the testing set) with clinicopathologically confirmed stage II CRC. Then, we built two CT radiomics models by using primary tumor and LN image features, respectively. The radiomics model development process included tumor or LN segmentation, feature extraction and selection, synthetic minority oversampling technique (SMOTE) oversampling, and support vector machine classifier training/testing. In order to improve the radiomics model performance, we used an information fusion method to build a fusion radiomics model by combining tumor and LN image features. Meanwhile, we applied a transfer learning method to build a deep convolutional neural network (CNN) model to predict the prognosis of CRC patients. Finally, we fused the prediction scores generated by radiomics model and CNN model to improve the prognosis prediction performance. Results: The DFS and OS prediction AUC values generated by fusion model improved to 0.76±0.08 (95% CI: [0.57, 0.89]) and 0.91±0.05 (95% CI: [0.77, 0.97]), which were significantly higher than the AUC values generated by the models using CT radiomics feature and deep image feature individually. Applying survival analysis method, the DFS fusion model and OS fusion model yielded a concordance index (C-index) value of 0.73 (95% CI: [0.56, 0.89]), and 0.9 (95% CI: [0.83, 0.97]), respectively. Conclusion: The present study developed an artificial intelligence (AI) model to predict the prognosis of stage II CRC by radiomics and DL analysis of primary lesion and peripheral LNs in CT scan that can assist clinical screening of high-risk patients with poor prognosis to achieve precision medicine. Funding Statement: National Natural Science Foundation of China (Grant No. 81971687). Declaration of Interests: None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report. Ethics Approval Statement: Our Institutional Review Board (Fudan University Shanghai Cancer Center Medical Ethics Committee) approved this study and waived the need for informed consent from patients.
What problem does this paper attempt to address?